1. Home/
  2. Compounds/
  3. selumetinib:navitoclax (8:1 mol/mol)

selumetinib:navitoclax (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:navitoclax (8:1 mol/mol)
PharmacoGx selumetinib:navitoclax (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:navitoclax (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPN CTRPv2 pan-cancer AAC 0.29 3e-09
mRNA BAHCC1 CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA PIWIL4 CTRPv2 pan-cancer AAC 0.22 3e-09
mRNA METAP2 CTRPv2 pan-cancer AAC -0.21 5e-09
mRNA PARVG CTRPv2 pan-cancer AAC 0.23 5e-09
mRNA RPS6KA1 CTRPv2 pan-cancer AAC 0.24 7e-09
mRNA GPR75-ASB3 CTRPv2 pan-cancer AAC -0.22 7e-09
mRNA LRCH4 CTRPv2 pan-cancer AAC 0.22 7e-09
mRNA MYO15B CTRPv2 pan-cancer AAC 0.22 8e-09
mRNA DEF8 CTRPv2 pan-cancer AAC -0.2 9e-09
Download CSV